Citation: Y. Cao et al., A sensitive chemiluminescent enzyme immunoassay for the bioanalysis of carboxyl-terminal B-chain analogues of human insulin, J PHARM B, 26(1), 2001, pp. 53-61
Authors:
Budman, DR
Johnson, R
Barile, B
Bowsher, RR
Vinciguerra, V
Allen, SL
Kolitz, J
Ernest, CS
Kreis, W
Zervos, P
Walling, J
Citation: Dr. Budman et al., Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis, CANC CHEMOT, 47(6), 2001, pp. 525-531
Authors:
Brown-Augsburger, P
Masnyk, M
Santa, P
Gingerich, RL
Bowsher, RR
Citation: P. Brown-augsburger et al., An immunoadsorption strategy to produce specific antisera against analogs of human proteins: development of sensitive and specific radioimmunoassays for two analogs of human leptin, J PHARM B, 23(4), 2000, pp. 687-696
Authors:
Findlay, JWA
Smith, WC
Lee, JW
Nordblom, GD
Das, I
DeSilva, BS
Khan, MN
Bowsher, RR
Citation: Jwa. Findlay et al., Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective, J PHARM B, 21(6), 2000, pp. 1249-1273
Authors:
Graf, CJ
Woodworth, JR
Seger, ME
Holcombe, JH
Bowsher, RR
Lynch, R
Citation: Cj. Graf et al., Pharmacokinetic and glucodynamic comparisons of recombinant and animal-source glucagon after IV, IM, and SC injection in healthy volunteers, J PHARM SCI, 88(10), 1999, pp. 991-995
Authors:
Boyle, DW
Denne, SC
Moorehead, H
Lee, WH
Bowsher, RR
Liechty, EA
Citation: Dw. Boyle et al., Effect of rhIGF-I infusion on whole fetal and fetal skeletal muscle protein metabolism in sheep, AM J P-ENDO, 38(6), 1998, pp. E1082-E1091